Global H1N1 Influenza A Vaccine Market Growth 2026-2032
The global H1N1 Influenza A Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for H1N1 Influenza A Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for H1N1 Influenza A Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for H1N1 Influenza A Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key H1N1 Influenza A Vaccine players cover Sanofi, Beijing Institute of Biological Products, Sinovac Biotech, Fosun Yalifeng (Dalian) Biopharmaceutical, Shanghai Institute Of Biological Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “H1N1 Influenza A Vaccine Industry Forecast” looks at past sales and reviews total world H1N1 Influenza A Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected H1N1 Influenza A Vaccine sales for 2026 through 2032. With H1N1 Influenza A Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world H1N1 Influenza A Vaccine industry.
This Insight Report provides a comprehensive analysis of the global H1N1 Influenza A Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on H1N1 Influenza A Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global H1N1 Influenza A Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for H1N1 Influenza A Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global H1N1 Influenza A Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of H1N1 Influenza A Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
United States market for H1N1 Influenza A Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for H1N1 Influenza A Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for H1N1 Influenza A Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key H1N1 Influenza A Vaccine players cover Sanofi, Beijing Institute of Biological Products, Sinovac Biotech, Fosun Yalifeng (Dalian) Biopharmaceutical, Shanghai Institute Of Biological Products, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “H1N1 Influenza A Vaccine Industry Forecast” looks at past sales and reviews total world H1N1 Influenza A Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected H1N1 Influenza A Vaccine sales for 2026 through 2032. With H1N1 Influenza A Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world H1N1 Influenza A Vaccine industry.
This Insight Report provides a comprehensive analysis of the global H1N1 Influenza A Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on H1N1 Influenza A Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global H1N1 Influenza A Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for H1N1 Influenza A Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global H1N1 Influenza A Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of H1N1 Influenza A Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 0.5mL/Tube
- Others
- Underage
- Aldult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Sanofi
- Beijing Institute of Biological Products
- Sinovac Biotech
- Fosun Yalifeng (Dalian) Biopharmaceutical
- Shanghai Institute Of Biological Products
- Hualan Biological Engineering
- Lanzhou Biological Products
- What is the 10-year outlook for the global H1N1 Influenza A Vaccine market?
- What factors are driving H1N1 Influenza A Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do H1N1 Influenza A Vaccine market opportunities vary by end market size?
- How does H1N1 Influenza A Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global H1N1 Influenza A Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for H1N1 Influenza A Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for H1N1 Influenza A Vaccine by Country/Region, 2021, 2025 & 2032
2.2 H1N1 Influenza A Vaccine Segment by Type
2.2.1 0.5mL/Tube
2.2.2 Others
2.2.3 H1N1 Influenza A Vaccine Sales by Type
2.2.3.1 Global H1N1 Influenza A Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global H1N1 Influenza A Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global H1N1 Influenza A Vaccine Sale Price by Type (2021-2026)
2.3 H1N1 Influenza A Vaccine Segment by Application
2.3.1 Underage
2.3.2 Aldult
2.3.3 H1N1 Influenza A Vaccine Sales by Application
2.3.3.1 Global H1N1 Influenza A Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global H1N1 Influenza A Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global H1N1 Influenza A Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global H1N1 Influenza A Vaccine Breakdown Data by Company
3.1.1 Global H1N1 Influenza A Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global H1N1 Influenza A Vaccine Sales Market Share by Company (2021-2026)
3.2 Global H1N1 Influenza A Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global H1N1 Influenza A Vaccine Revenue by Company (2021-2026)
3.2.2 Global H1N1 Influenza A Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global H1N1 Influenza A Vaccine Sale Price by Company
3.4 Key Manufacturers H1N1 Influenza A Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers H1N1 Influenza A Vaccine Product Location Distribution
3.4.2 Players H1N1 Influenza A Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR H1N1 INFLUENZA A VACCINE BY GEOGRAPHIC REGION
4.1 World Historic H1N1 Influenza A Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global H1N1 Influenza A Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global H1N1 Influenza A Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic H1N1 Influenza A Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global H1N1 Influenza A Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global H1N1 Influenza A Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas H1N1 Influenza A Vaccine Sales Growth
4.4 APAC H1N1 Influenza A Vaccine Sales Growth
4.5 Europe H1N1 Influenza A Vaccine Sales Growth
4.6 Middle East & Africa H1N1 Influenza A Vaccine Sales Growth
5 AMERICAS
5.1 Americas H1N1 Influenza A Vaccine Sales by Country
5.1.1 Americas H1N1 Influenza A Vaccine Sales by Country (2021-2026)
5.1.2 Americas H1N1 Influenza A Vaccine Revenue by Country (2021-2026)
5.2 Americas H1N1 Influenza A Vaccine Sales by Type (2021-2026)
5.3 Americas H1N1 Influenza A Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC H1N1 Influenza A Vaccine Sales by Region
6.1.1 APAC H1N1 Influenza A Vaccine Sales by Region (2021-2026)
6.1.2 APAC H1N1 Influenza A Vaccine Revenue by Region (2021-2026)
6.2 APAC H1N1 Influenza A Vaccine Sales by Type (2021-2026)
6.3 APAC H1N1 Influenza A Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe H1N1 Influenza A Vaccine by Country
7.1.1 Europe H1N1 Influenza A Vaccine Sales by Country (2021-2026)
7.1.2 Europe H1N1 Influenza A Vaccine Revenue by Country (2021-2026)
7.2 Europe H1N1 Influenza A Vaccine Sales by Type (2021-2026)
7.3 Europe H1N1 Influenza A Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa H1N1 Influenza A Vaccine by Country
8.1.1 Middle East & Africa H1N1 Influenza A Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa H1N1 Influenza A Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa H1N1 Influenza A Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa H1N1 Influenza A Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of H1N1 Influenza A Vaccine
10.3 Manufacturing Process Analysis of H1N1 Influenza A Vaccine
10.4 Industry Chain Structure of H1N1 Influenza A Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 H1N1 Influenza A Vaccine Distributors
11.3 H1N1 Influenza A Vaccine Customer
12 WORLD FORECAST REVIEW FOR H1N1 INFLUENZA A VACCINE BY GEOGRAPHIC REGION
12.1 Global H1N1 Influenza A Vaccine Market Size Forecast by Region
12.1.1 Global H1N1 Influenza A Vaccine Forecast by Region (2027-2032)
12.1.2 Global H1N1 Influenza A Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global H1N1 Influenza A Vaccine Forecast by Type (2027-2032)
12.7 Global H1N1 Influenza A Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi H1N1 Influenza A Vaccine Product Portfolios and Specifications
13.1.3 Sanofi H1N1 Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Beijing Institute of Biological Products
13.2.1 Beijing Institute of Biological Products Company Information
13.2.2 Beijing Institute of Biological Products H1N1 Influenza A Vaccine Product Portfolios and Specifications
13.2.3 Beijing Institute of Biological Products H1N1 Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Beijing Institute of Biological Products Main Business Overview
13.2.5 Beijing Institute of Biological Products Latest Developments
13.3 Sinovac Biotech
13.3.1 Sinovac Biotech Company Information
13.3.2 Sinovac Biotech H1N1 Influenza A Vaccine Product Portfolios and Specifications
13.3.3 Sinovac Biotech H1N1 Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sinovac Biotech Main Business Overview
13.3.5 Sinovac Biotech Latest Developments
13.4 Fosun Yalifeng (Dalian) Biopharmaceutical
13.4.1 Fosun Yalifeng (Dalian) Biopharmaceutical Company Information
13.4.2 Fosun Yalifeng (Dalian) Biopharmaceutical H1N1 Influenza A Vaccine Product Portfolios and Specifications
13.4.3 Fosun Yalifeng (Dalian) Biopharmaceutical H1N1 Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Fosun Yalifeng (Dalian) Biopharmaceutical Main Business Overview
13.4.5 Fosun Yalifeng (Dalian) Biopharmaceutical Latest Developments
13.5 Shanghai Institute Of Biological Products
13.5.1 Shanghai Institute Of Biological Products Company Information
13.5.2 Shanghai Institute Of Biological Products H1N1 Influenza A Vaccine Product Portfolios and Specifications
13.5.3 Shanghai Institute Of Biological Products H1N1 Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Shanghai Institute Of Biological Products Main Business Overview
13.5.5 Shanghai Institute Of Biological Products Latest Developments
13.6 Hualan Biological Engineering
13.6.1 Hualan Biological Engineering Company Information
13.6.2 Hualan Biological Engineering H1N1 Influenza A Vaccine Product Portfolios and Specifications
13.6.3 Hualan Biological Engineering H1N1 Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hualan Biological Engineering Main Business Overview
13.6.5 Hualan Biological Engineering Latest Developments
13.7 Lanzhou Biological Products
13.7.1 Lanzhou Biological Products Company Information
13.7.2 Lanzhou Biological Products H1N1 Influenza A Vaccine Product Portfolios and Specifications
13.7.3 Lanzhou Biological Products H1N1 Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Lanzhou Biological Products Main Business Overview
13.7.5 Lanzhou Biological Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global H1N1 Influenza A Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for H1N1 Influenza A Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for H1N1 Influenza A Vaccine by Country/Region, 2021, 2025 & 2032
2.2 H1N1 Influenza A Vaccine Segment by Type
2.2.1 0.5mL/Tube
2.2.2 Others
2.2.3 H1N1 Influenza A Vaccine Sales by Type
2.2.3.1 Global H1N1 Influenza A Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global H1N1 Influenza A Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global H1N1 Influenza A Vaccine Sale Price by Type (2021-2026)
2.3 H1N1 Influenza A Vaccine Segment by Application
2.3.1 Underage
2.3.2 Aldult
2.3.3 H1N1 Influenza A Vaccine Sales by Application
2.3.3.1 Global H1N1 Influenza A Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global H1N1 Influenza A Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global H1N1 Influenza A Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global H1N1 Influenza A Vaccine Breakdown Data by Company
3.1.1 Global H1N1 Influenza A Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global H1N1 Influenza A Vaccine Sales Market Share by Company (2021-2026)
3.2 Global H1N1 Influenza A Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global H1N1 Influenza A Vaccine Revenue by Company (2021-2026)
3.2.2 Global H1N1 Influenza A Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global H1N1 Influenza A Vaccine Sale Price by Company
3.4 Key Manufacturers H1N1 Influenza A Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers H1N1 Influenza A Vaccine Product Location Distribution
3.4.2 Players H1N1 Influenza A Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR H1N1 INFLUENZA A VACCINE BY GEOGRAPHIC REGION
4.1 World Historic H1N1 Influenza A Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global H1N1 Influenza A Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global H1N1 Influenza A Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic H1N1 Influenza A Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global H1N1 Influenza A Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global H1N1 Influenza A Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas H1N1 Influenza A Vaccine Sales Growth
4.4 APAC H1N1 Influenza A Vaccine Sales Growth
4.5 Europe H1N1 Influenza A Vaccine Sales Growth
4.6 Middle East & Africa H1N1 Influenza A Vaccine Sales Growth
5 AMERICAS
5.1 Americas H1N1 Influenza A Vaccine Sales by Country
5.1.1 Americas H1N1 Influenza A Vaccine Sales by Country (2021-2026)
5.1.2 Americas H1N1 Influenza A Vaccine Revenue by Country (2021-2026)
5.2 Americas H1N1 Influenza A Vaccine Sales by Type (2021-2026)
5.3 Americas H1N1 Influenza A Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC H1N1 Influenza A Vaccine Sales by Region
6.1.1 APAC H1N1 Influenza A Vaccine Sales by Region (2021-2026)
6.1.2 APAC H1N1 Influenza A Vaccine Revenue by Region (2021-2026)
6.2 APAC H1N1 Influenza A Vaccine Sales by Type (2021-2026)
6.3 APAC H1N1 Influenza A Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe H1N1 Influenza A Vaccine by Country
7.1.1 Europe H1N1 Influenza A Vaccine Sales by Country (2021-2026)
7.1.2 Europe H1N1 Influenza A Vaccine Revenue by Country (2021-2026)
7.2 Europe H1N1 Influenza A Vaccine Sales by Type (2021-2026)
7.3 Europe H1N1 Influenza A Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa H1N1 Influenza A Vaccine by Country
8.1.1 Middle East & Africa H1N1 Influenza A Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa H1N1 Influenza A Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa H1N1 Influenza A Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa H1N1 Influenza A Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of H1N1 Influenza A Vaccine
10.3 Manufacturing Process Analysis of H1N1 Influenza A Vaccine
10.4 Industry Chain Structure of H1N1 Influenza A Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 H1N1 Influenza A Vaccine Distributors
11.3 H1N1 Influenza A Vaccine Customer
12 WORLD FORECAST REVIEW FOR H1N1 INFLUENZA A VACCINE BY GEOGRAPHIC REGION
12.1 Global H1N1 Influenza A Vaccine Market Size Forecast by Region
12.1.1 Global H1N1 Influenza A Vaccine Forecast by Region (2027-2032)
12.1.2 Global H1N1 Influenza A Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global H1N1 Influenza A Vaccine Forecast by Type (2027-2032)
12.7 Global H1N1 Influenza A Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi H1N1 Influenza A Vaccine Product Portfolios and Specifications
13.1.3 Sanofi H1N1 Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 Beijing Institute of Biological Products
13.2.1 Beijing Institute of Biological Products Company Information
13.2.2 Beijing Institute of Biological Products H1N1 Influenza A Vaccine Product Portfolios and Specifications
13.2.3 Beijing Institute of Biological Products H1N1 Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Beijing Institute of Biological Products Main Business Overview
13.2.5 Beijing Institute of Biological Products Latest Developments
13.3 Sinovac Biotech
13.3.1 Sinovac Biotech Company Information
13.3.2 Sinovac Biotech H1N1 Influenza A Vaccine Product Portfolios and Specifications
13.3.3 Sinovac Biotech H1N1 Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Sinovac Biotech Main Business Overview
13.3.5 Sinovac Biotech Latest Developments
13.4 Fosun Yalifeng (Dalian) Biopharmaceutical
13.4.1 Fosun Yalifeng (Dalian) Biopharmaceutical Company Information
13.4.2 Fosun Yalifeng (Dalian) Biopharmaceutical H1N1 Influenza A Vaccine Product Portfolios and Specifications
13.4.3 Fosun Yalifeng (Dalian) Biopharmaceutical H1N1 Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Fosun Yalifeng (Dalian) Biopharmaceutical Main Business Overview
13.4.5 Fosun Yalifeng (Dalian) Biopharmaceutical Latest Developments
13.5 Shanghai Institute Of Biological Products
13.5.1 Shanghai Institute Of Biological Products Company Information
13.5.2 Shanghai Institute Of Biological Products H1N1 Influenza A Vaccine Product Portfolios and Specifications
13.5.3 Shanghai Institute Of Biological Products H1N1 Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Shanghai Institute Of Biological Products Main Business Overview
13.5.5 Shanghai Institute Of Biological Products Latest Developments
13.6 Hualan Biological Engineering
13.6.1 Hualan Biological Engineering Company Information
13.6.2 Hualan Biological Engineering H1N1 Influenza A Vaccine Product Portfolios and Specifications
13.6.3 Hualan Biological Engineering H1N1 Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Hualan Biological Engineering Main Business Overview
13.6.5 Hualan Biological Engineering Latest Developments
13.7 Lanzhou Biological Products
13.7.1 Lanzhou Biological Products Company Information
13.7.2 Lanzhou Biological Products H1N1 Influenza A Vaccine Product Portfolios and Specifications
13.7.3 Lanzhou Biological Products H1N1 Influenza A Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Lanzhou Biological Products Main Business Overview
13.7.5 Lanzhou Biological Products Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. H1N1 Influenza A Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. H1N1 Influenza A Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 0.5mL/Tube
Table 4. Major Players of Others
Table 5. Global H1N1 Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global H1N1 Influenza A Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global H1N1 Influenza A Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global H1N1 Influenza A Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global H1N1 Influenza A Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global H1N1 Influenza A Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global H1N1 Influenza A Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global H1N1 Influenza A Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global H1N1 Influenza A Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global H1N1 Influenza A Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global H1N1 Influenza A Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global H1N1 Influenza A Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global H1N1 Influenza A Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global H1N1 Influenza A Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global H1N1 Influenza A Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers H1N1 Influenza A Vaccine Producing Area Distribution and Sales Area
Table 21. Players H1N1 Influenza A Vaccine Products Offered
Table 22. H1N1 Influenza A Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global H1N1 Influenza A Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global H1N1 Influenza A Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global H1N1 Influenza A Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global H1N1 Influenza A Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global H1N1 Influenza A Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global H1N1 Influenza A Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global H1N1 Influenza A Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global H1N1 Influenza A Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas H1N1 Influenza A Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas H1N1 Influenza A Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas H1N1 Influenza A Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas H1N1 Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas H1N1 Influenza A Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC H1N1 Influenza A Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC H1N1 Influenza A Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC H1N1 Influenza A Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC H1N1 Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC H1N1 Influenza A Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe H1N1 Influenza A Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe H1N1 Influenza A Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe H1N1 Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe H1N1 Influenza A Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa H1N1 Influenza A Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa H1N1 Influenza A Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa H1N1 Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa H1N1 Influenza A Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of H1N1 Influenza A Vaccine
Table 52. Key Market Challenges & Risks of H1N1 Influenza A Vaccine
Table 53. Key Industry Trends of H1N1 Influenza A Vaccine
Table 54. H1N1 Influenza A Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. H1N1 Influenza A Vaccine Distributors List
Table 57. H1N1 Influenza A Vaccine Customer List
Table 58. Global H1N1 Influenza A Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global H1N1 Influenza A Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas H1N1 Influenza A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas H1N1 Influenza A Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC H1N1 Influenza A Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC H1N1 Influenza A Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe H1N1 Influenza A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe H1N1 Influenza A Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa H1N1 Influenza A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa H1N1 Influenza A Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global H1N1 Influenza A Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global H1N1 Influenza A Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global H1N1 Influenza A Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global H1N1 Influenza A Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Sanofi Basic Information, H1N1 Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi H1N1 Influenza A Vaccine Product Portfolios and Specifications
Table 74. Sanofi H1N1 Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. Beijing Institute of Biological Products Basic Information, H1N1 Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Beijing Institute of Biological Products H1N1 Influenza A Vaccine Product Portfolios and Specifications
Table 79. Beijing Institute of Biological Products H1N1 Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Beijing Institute of Biological Products Main Business
Table 81. Beijing Institute of Biological Products Latest Developments
Table 82. Sinovac Biotech Basic Information, H1N1 Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Sinovac Biotech H1N1 Influenza A Vaccine Product Portfolios and Specifications
Table 84. Sinovac Biotech H1N1 Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sinovac Biotech Main Business
Table 86. Sinovac Biotech Latest Developments
Table 87. Fosun Yalifeng (Dalian) Biopharmaceutical Basic Information, H1N1 Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Fosun Yalifeng (Dalian) Biopharmaceutical H1N1 Influenza A Vaccine Product Portfolios and Specifications
Table 89. Fosun Yalifeng (Dalian) Biopharmaceutical H1N1 Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Fosun Yalifeng (Dalian) Biopharmaceutical Main Business
Table 91. Fosun Yalifeng (Dalian) Biopharmaceutical Latest Developments
Table 92. Shanghai Institute Of Biological Products Basic Information, H1N1 Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Shanghai Institute Of Biological Products H1N1 Influenza A Vaccine Product Portfolios and Specifications
Table 94. Shanghai Institute Of Biological Products H1N1 Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Shanghai Institute Of Biological Products Main Business
Table 96. Shanghai Institute Of Biological Products Latest Developments
Table 97. Hualan Biological Engineering Basic Information, H1N1 Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Hualan Biological Engineering H1N1 Influenza A Vaccine Product Portfolios and Specifications
Table 99. Hualan Biological Engineering H1N1 Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Hualan Biological Engineering Main Business
Table 101. Hualan Biological Engineering Latest Developments
Table 102. Lanzhou Biological Products Basic Information, H1N1 Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Lanzhou Biological Products H1N1 Influenza A Vaccine Product Portfolios and Specifications
Table 104. Lanzhou Biological Products H1N1 Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Lanzhou Biological Products Main Business
Table 106. Lanzhou Biological Products Latest Developments
Table 1. H1N1 Influenza A Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. H1N1 Influenza A Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 0.5mL/Tube
Table 4. Major Players of Others
Table 5. Global H1N1 Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 6. Global H1N1 Influenza A Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global H1N1 Influenza A Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global H1N1 Influenza A Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global H1N1 Influenza A Vaccine Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global H1N1 Influenza A Vaccine Sale by Application (2021-2026) & (K Units)
Table 11. Global H1N1 Influenza A Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global H1N1 Influenza A Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global H1N1 Influenza A Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global H1N1 Influenza A Vaccine Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global H1N1 Influenza A Vaccine Sales by Company (2021-2026) & (K Units)
Table 16. Global H1N1 Influenza A Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global H1N1 Influenza A Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global H1N1 Influenza A Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global H1N1 Influenza A Vaccine Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers H1N1 Influenza A Vaccine Producing Area Distribution and Sales Area
Table 21. Players H1N1 Influenza A Vaccine Products Offered
Table 22. H1N1 Influenza A Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global H1N1 Influenza A Vaccine Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global H1N1 Influenza A Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global H1N1 Influenza A Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global H1N1 Influenza A Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global H1N1 Influenza A Vaccine Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global H1N1 Influenza A Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global H1N1 Influenza A Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global H1N1 Influenza A Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas H1N1 Influenza A Vaccine Sales by Country (2021-2026) & (K Units)
Table 34. Americas H1N1 Influenza A Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas H1N1 Influenza A Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas H1N1 Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 37. Americas H1N1 Influenza A Vaccine Sales by Application (2021-2026) & (K Units)
Table 38. APAC H1N1 Influenza A Vaccine Sales by Region (2021-2026) & (K Units)
Table 39. APAC H1N1 Influenza A Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC H1N1 Influenza A Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC H1N1 Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 42. APAC H1N1 Influenza A Vaccine Sales by Application (2021-2026) & (K Units)
Table 43. Europe H1N1 Influenza A Vaccine Sales by Country (2021-2026) & (K Units)
Table 44. Europe H1N1 Influenza A Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe H1N1 Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 46. Europe H1N1 Influenza A Vaccine Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa H1N1 Influenza A Vaccine Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa H1N1 Influenza A Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa H1N1 Influenza A Vaccine Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa H1N1 Influenza A Vaccine Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of H1N1 Influenza A Vaccine
Table 52. Key Market Challenges & Risks of H1N1 Influenza A Vaccine
Table 53. Key Industry Trends of H1N1 Influenza A Vaccine
Table 54. H1N1 Influenza A Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. H1N1 Influenza A Vaccine Distributors List
Table 57. H1N1 Influenza A Vaccine Customer List
Table 58. Global H1N1 Influenza A Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global H1N1 Influenza A Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas H1N1 Influenza A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas H1N1 Influenza A Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC H1N1 Influenza A Vaccine Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC H1N1 Influenza A Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe H1N1 Influenza A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe H1N1 Influenza A Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa H1N1 Influenza A Vaccine Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa H1N1 Influenza A Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global H1N1 Influenza A Vaccine Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global H1N1 Influenza A Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global H1N1 Influenza A Vaccine Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global H1N1 Influenza A Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Sanofi Basic Information, H1N1 Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Sanofi H1N1 Influenza A Vaccine Product Portfolios and Specifications
Table 74. Sanofi H1N1 Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Sanofi Main Business
Table 76. Sanofi Latest Developments
Table 77. Beijing Institute of Biological Products Basic Information, H1N1 Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. Beijing Institute of Biological Products H1N1 Influenza A Vaccine Product Portfolios and Specifications
Table 79. Beijing Institute of Biological Products H1N1 Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Beijing Institute of Biological Products Main Business
Table 81. Beijing Institute of Biological Products Latest Developments
Table 82. Sinovac Biotech Basic Information, H1N1 Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Sinovac Biotech H1N1 Influenza A Vaccine Product Portfolios and Specifications
Table 84. Sinovac Biotech H1N1 Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sinovac Biotech Main Business
Table 86. Sinovac Biotech Latest Developments
Table 87. Fosun Yalifeng (Dalian) Biopharmaceutical Basic Information, H1N1 Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Fosun Yalifeng (Dalian) Biopharmaceutical H1N1 Influenza A Vaccine Product Portfolios and Specifications
Table 89. Fosun Yalifeng (Dalian) Biopharmaceutical H1N1 Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Fosun Yalifeng (Dalian) Biopharmaceutical Main Business
Table 91. Fosun Yalifeng (Dalian) Biopharmaceutical Latest Developments
Table 92. Shanghai Institute Of Biological Products Basic Information, H1N1 Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 93. Shanghai Institute Of Biological Products H1N1 Influenza A Vaccine Product Portfolios and Specifications
Table 94. Shanghai Institute Of Biological Products H1N1 Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Shanghai Institute Of Biological Products Main Business
Table 96. Shanghai Institute Of Biological Products Latest Developments
Table 97. Hualan Biological Engineering Basic Information, H1N1 Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 98. Hualan Biological Engineering H1N1 Influenza A Vaccine Product Portfolios and Specifications
Table 99. Hualan Biological Engineering H1N1 Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Hualan Biological Engineering Main Business
Table 101. Hualan Biological Engineering Latest Developments
Table 102. Lanzhou Biological Products Basic Information, H1N1 Influenza A Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 103. Lanzhou Biological Products H1N1 Influenza A Vaccine Product Portfolios and Specifications
Table 104. Lanzhou Biological Products H1N1 Influenza A Vaccine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Lanzhou Biological Products Main Business
Table 106. Lanzhou Biological Products Latest Developments
LIST OF FIGURES
Figure 1. Picture of H1N1 Influenza A Vaccine
Figure 2. H1N1 Influenza A Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global H1N1 Influenza A Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global H1N1 Influenza A Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. H1N1 Influenza A Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. H1N1 Influenza A Vaccine Sales Market Share by Country/Region (2025)
Figure 10. H1N1 Influenza A Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 0.5mL/Tube
Figure 12. Product Picture of Others
Figure 13. Global H1N1 Influenza A Vaccine Sales Market Share by Type in 2026
Figure 14. Global H1N1 Influenza A Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. H1N1 Influenza A Vaccine Consumed in Underage
Figure 16. Global H1N1 Influenza A Vaccine Market: Underage (2021-2026) & (K Units)
Figure 17. H1N1 Influenza A Vaccine Consumed in Aldult
Figure 18. Global H1N1 Influenza A Vaccine Market: Aldult (2021-2026) & (K Units)
Figure 19. Global H1N1 Influenza A Vaccine Sale Market Share by Application (2025)
Figure 20. Global H1N1 Influenza A Vaccine Revenue Market Share by Application in 2026
Figure 21. H1N1 Influenza A Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global H1N1 Influenza A Vaccine Sales Market Share by Company in 2026
Figure 23. H1N1 Influenza A Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global H1N1 Influenza A Vaccine Revenue Market Share by Company in 2026
Figure 25. Global H1N1 Influenza A Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global H1N1 Influenza A Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas H1N1 Influenza A Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas H1N1 Influenza A Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC H1N1 Influenza A Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC H1N1 Influenza A Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe H1N1 Influenza A Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe H1N1 Influenza A Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa H1N1 Influenza A Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa H1N1 Influenza A Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas H1N1 Influenza A Vaccine Sales Market Share by Country in 2026
Figure 36. Americas H1N1 Influenza A Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas H1N1 Influenza A Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas H1N1 Influenza A Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC H1N1 Influenza A Vaccine Sales Market Share by Region in 2026
Figure 44. APAC H1N1 Influenza A Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC H1N1 Influenza A Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC H1N1 Influenza A Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe H1N1 Influenza A Vaccine Sales Market Share by Country in 2026
Figure 55. Europe H1N1 Influenza A Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe H1N1 Influenza A Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe H1N1 Influenza A Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa H1N1 Influenza A Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa H1N1 Influenza A Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa H1N1 Influenza A Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of H1N1 Influenza A Vaccine in 2026
Figure 72. Manufacturing Process Analysis of H1N1 Influenza A Vaccine
Figure 73. Industry Chain Structure of H1N1 Influenza A Vaccine
Figure 74. Channels of Distribution
Figure 75. Global H1N1 Influenza A Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global H1N1 Influenza A Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global H1N1 Influenza A Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global H1N1 Influenza A Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global H1N1 Influenza A Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global H1N1 Influenza A Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of H1N1 Influenza A Vaccine
Figure 2. H1N1 Influenza A Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global H1N1 Influenza A Vaccine Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global H1N1 Influenza A Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. H1N1 Influenza A Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. H1N1 Influenza A Vaccine Sales Market Share by Country/Region (2025)
Figure 10. H1N1 Influenza A Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 0.5mL/Tube
Figure 12. Product Picture of Others
Figure 13. Global H1N1 Influenza A Vaccine Sales Market Share by Type in 2026
Figure 14. Global H1N1 Influenza A Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. H1N1 Influenza A Vaccine Consumed in Underage
Figure 16. Global H1N1 Influenza A Vaccine Market: Underage (2021-2026) & (K Units)
Figure 17. H1N1 Influenza A Vaccine Consumed in Aldult
Figure 18. Global H1N1 Influenza A Vaccine Market: Aldult (2021-2026) & (K Units)
Figure 19. Global H1N1 Influenza A Vaccine Sale Market Share by Application (2025)
Figure 20. Global H1N1 Influenza A Vaccine Revenue Market Share by Application in 2026
Figure 21. H1N1 Influenza A Vaccine Sales by Company in 2026 (K Units)
Figure 22. Global H1N1 Influenza A Vaccine Sales Market Share by Company in 2026
Figure 23. H1N1 Influenza A Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global H1N1 Influenza A Vaccine Revenue Market Share by Company in 2026
Figure 25. Global H1N1 Influenza A Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global H1N1 Influenza A Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas H1N1 Influenza A Vaccine Sales 2021-2026 (K Units)
Figure 28. Americas H1N1 Influenza A Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC H1N1 Influenza A Vaccine Sales 2021-2026 (K Units)
Figure 30. APAC H1N1 Influenza A Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe H1N1 Influenza A Vaccine Sales 2021-2026 (K Units)
Figure 32. Europe H1N1 Influenza A Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa H1N1 Influenza A Vaccine Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa H1N1 Influenza A Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas H1N1 Influenza A Vaccine Sales Market Share by Country in 2026
Figure 36. Americas H1N1 Influenza A Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas H1N1 Influenza A Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas H1N1 Influenza A Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC H1N1 Influenza A Vaccine Sales Market Share by Region in 2026
Figure 44. APAC H1N1 Influenza A Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC H1N1 Influenza A Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC H1N1 Influenza A Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe H1N1 Influenza A Vaccine Sales Market Share by Country in 2026
Figure 55. Europe H1N1 Influenza A Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe H1N1 Influenza A Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe H1N1 Influenza A Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa H1N1 Influenza A Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa H1N1 Influenza A Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa H1N1 Influenza A Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries H1N1 Influenza A Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of H1N1 Influenza A Vaccine in 2026
Figure 72. Manufacturing Process Analysis of H1N1 Influenza A Vaccine
Figure 73. Industry Chain Structure of H1N1 Influenza A Vaccine
Figure 74. Channels of Distribution
Figure 75. Global H1N1 Influenza A Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global H1N1 Influenza A Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global H1N1 Influenza A Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global H1N1 Influenza A Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global H1N1 Influenza A Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global H1N1 Influenza A Vaccine Revenue Market Share Forecast by Application (2027-2032)
